Navigation Links
After-Effects of Chemotherapy May Include Memory Problems
Date:9/23/2009

Lack of concentration, thinking difficulties reported by breast cancer survivors, researchers say

WEDNESDAY, Sept. 23 (HealthDay News) -- Chemotherapy can save the lives of people with cancer, but new research suggests it may have devastating effects on the brain.

Many cancer patients who receive chemotherapy report "chemobrain" -- a range of symptoms including a loss of memory and the ability to concentrate, and other problems such as difficulty thinking.

The stories of women who survived breast cancer but suffered from weakened brain power are told in a study published online Sept. 16 in the Journal of Cancer Survivorship.

Saskia Subramanian, from the Center for Culture and Health at the University of California -- Los Angeles, and colleagues interviewed 74 women who had completed cancer treatment at least a year earlier. The women described a variety of emotions, including fear, frustration and emotional exhaustion.

In some cases, women stated that they feared losing their independence because they wouldn't be able to take care of themselves like before. They sometimes devoted less time to work and to social activities, and felt that the medical community didn't pay enough attention to their symptoms of chemobrain, according to a news release about the study.

At the workplace, the side effects of chemotherapy robbed their ability to focus, potentially making it less likely that they'd be promoted, the study authors pointed out.

"These data underscore the very serious ways in which chemobrain can affect the life experiences of cancer survivors -- emotionally, psychologically and economically," the researchers concluded. "A clear understanding of the cognitive impairments experienced by survivors will aid researchers in developing targeted therapies and interventions aimed at improving or mitigating these post-treatment side effects."

More information

The American Cancer Society has more on chemobrain.



-- Randy Dotinga



SOURCE: Journal of Cancer Survivorship, news release, Sept. 17, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Nexavar in Combination With Chemotherapy Demonstrates 74 Percent Improvement in Progression-Free Survival in Patients With Advanced Breast Cancer in Phase 2 Study
2. Yeast unravels effects of chemotherapy drugs
3. Chemotherapy Linked to Sleep-Wake Cycle Disruptions
4. Chemotherapy for breast cancer is associated with disruption of sleep-wake rhythm in women
5. JNCI news brief: Melanosome dynamics and sensitivity of melanoma cells to chemotherapy
6. JNCI news brief: Antibody linked to chemotherapy drug inhibits ovarian cancer in lab
7. Oral Chemotherapy Offers Patients a More Convenient, Less Invasive Treatment Option
8. Life after chemotherapy: Daily tasks, quality of life may be affected, MU researcher finds
9. Nexavar in Combination with Chemotherapy Shown to Extend Progression-Free Survival in Patients with Advanced Breast Cancer
10. Fluorescent probes may permit monitoring of chemotherapy effectiveness, Stanford study shows
11. Elderly breast cancer patients receive chemotherapy if treated in private practices
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
After-Effects of Chemotherapy May Include Memory Problems
(Date:12/9/2016)... - Cincinnati, Ohio (PRWEB) , ... December 09, ... ... the production of miniature, folded, pharmaceutical inserts and outserts. As a means ... Device. This addition will enable Flottman to individually code professional inserts (PIs) ...
(Date:12/9/2016)... ... December 09, 2016 , ... An inventor from Cana, Va., wanted to fulfill ... of amusement park rides. , The patent-pending SAFETY STRAP FOR AMPUTEES improves accessibility. It ... could be set up in a matter of minutes, or even seconds. The SAFETY ...
(Date:12/9/2016)... , ... December 09, 2016 , ... "I had a ... inventor from Winchester, Va. "I thought that if the nebulizer had a more child-friendly ... than fearing them." , He developed the patent-pending NEBY to avoid the need to ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... Research Institute (WCRI) officially opened registration today for its 33rd Annual Issues ... Boston, MA . , The theme of the conference is “Persistent Challenges and ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... Management (MTM), adherence, and other pharmacist-delivered patient care services, has announced the promotions ... Eric Hoessel to vice president of sales. , Litsinger joined Mirixa in ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... , Dec. 9, 2016  RxWiki Inc., a digital ... digital marketing strategies of thousands of pharmacies through its ... Austin Inno,s "50 on Fire" Award in ... "We,re pleased to accept the award as one of ... Chief Executive Officer at RxWiki. "Our platform gives independent ...
(Date:12/8/2016)... , Dec. 8, 2016 IRIDEX Corporation (NASDAQ: ... newly issued shares of common stock, $0.01 par value (the ... underwritten public offering.  The final terms of the Offering will ... pricing, and there can be no assurance as to whether ... expects to use the net proceeds it will receive from ...
(Date:12/8/2016)... , Dec. 8, 2016 Global Interventional ... on the global interventional radiology market analyzes the ... report comprises an elaborate executive summary, including a ... segments and sub-segments. The research is a ... formed the bulk of our research efforts along ...
Breaking Medicine Technology: